← Browse by Condition
Medical Condition
tumor
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2, Phase 1, Phase 2, Phase 1
NCT05064280 Phase 2
Recruiting
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
Enrollment
104 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06819215 Phase 1, Phase 2
Recruiting
Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors
Enrollment
188 pts
Location
China
Sponsor
Zhejiang Yangli Pharmaceutical...
NCT05661461 Phase 1
Recruiting
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment
Enrollment
28 pts
Location
United States
Sponsor
Aadi Bioscience, Inc.
NCT06690957
Recruiting
Somatostatin Receptor PET/CT in SSTR-Related Disease Patients
Enrollment
500 pts
Location
China
Sponsor
Tianjin Medical University
NCT07147465
Recruiting
Performance Indicators and Impact on the Care Pathway of Sequencing on the SeqOIA and AURAGEN (Seqogen) Platforms for Oncology Patients
Enrollment
3,149 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT06108232 Phase 2
Recruiting
Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
Enrollment
36 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center